Related Experiment Videos
Overview: pharmacogenomics of psychiatric disorders--separating the dreams from the realities
1NeuroBiz Consulting & Communications, Les Grèzes, La Verdarié, Castres, France. mike.briley@neurobiz.com
Current Opinion in Investigational Drugs (London, England : 2000)
|March 15, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project.
Journal of thrombosis and thrombolysis·2025
The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism.
Journal of psychopharmacology (Oxford, England)·2012
Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex.
Neurochemistry international·2010
In vivo [(3)H]ketanserin binding: effect of modifying synaptic serotonin levels.
Neurochemistry international·2010
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review.
Endocrinology, diabetes & metabolism·2026
Pharmacological lipid-lowering therapies for primary and secondary prevention of cardiovascular disease in adults with dyslipidaemia: a systematic review and network meta-analysis.
The Cochrane database of systematic reviews·2026
Synthesis of mannosides as potential inhibitors of PIMs biosynthesis in mycobacteria.
Organic & biomolecular chemistry·2026